Abstract:Purpose: Predicting the efficacy of radiotherapy in individual patients has drawn widespread attention, but the limited sample size remains a bottleneck for utilizing high-dimensional multi-omics data to guide personalized radiotherapy. We hypothesize the recently developed meta-learning framework could address this limitation. Methods and materials: By combining gene expression, DNA methylation, and clinical data of 806 patients who had received radiotherapy from The Cancer Genome Atlas (TCGA), we applied the Model-Agnostic Meta-Learning (MAML) framework to tasks consisting of pan-cancer data, to obtain the best initial parameters of a neural network for a specific cancer with smaller number of samples. The performance of meta-learning framework was compared with four traditional machine learning methods based on two training schemes, and tested on Cancer Cell Line Encyclopedia (CCLE) and Chinese Glioma Genome Atlas (CGGA) datasets. Moreover, biological significance of the models was investigated by survival analysis and feature interpretation. Results: The mean AUC (Area under the ROC Curve) [95% confidence interval] of our models across nine cancer types was 0.702 [0.691-0.713], which improved by 0.166 on average over other the four machine learning methods on two training schemes. Our models performed significantly better (p < 0.05) in seven cancer types and performed comparable to the other predictors in the rest of two cancer types. The more pan-cancer samples were used to transfer meta-knowledge, the greater the performance improved (p < 0.05). The predicted response scores that our models generated were negatively correlated with cell radiosensitivity index in four cancer types (p < 0.05), while not statistically significant in the other three cancer types. Moreover, the predicted response scores were shown to be prognostic factors in seven cancer types and eight potential radiosensitivity-related genes were identified. Conclusions: For the first time, we established the meta-learning approach to improving individual radiation response prediction by transferring common knowledge from pan-cancer data with MAML framework. The results demonstrated the superiority, generalizability, and biological significance of our approach.

Improving Reliability of Response Prediction to Platinum-Based Therapy by AdaBoost and Multiple Classifiers

Evaluation of Machine Learning Algorithms for the Prognosis of Breast Cancer from the Surveillance, Epidemiology, and End Results Database

Integration of Clinical Information and Gene Expression Profiles for Prediction of Chemo-Response for Ovarian Cancer

Ensemble Algorithm Based on Gene Selection, Data Augmentation, and Boosting Approaches for Ovarian Cancer Classification

Predictive Value of Machine Learning for Platinum Chemotherapy Responses in Ovarian Cancer: Systematic Review and Meta-Analysis

Prediction of Chemosensitivity in Multiple Primary Cancer Patients Using Machine Learning

Establishment of Chemotherapy Prediction Model Based on Hypoxia-Related Genes for Oral Cancer

A Hybrid Ensemble Algorithm Combining AdaBoost and Genetic Algorithm for Cancer Classification with Gene Expression Data.

Predicting Breast Cancer Chemotherapeutic Response Using a Novel Tool for Microarray Data Analysis.

Enhancing Chemotherapy Response Prediction via Matched Colorectal Tumor-Organoid Gene Expression Analysis and Network-Based Biomarker Selection

A meta-learning approach to improving radiation response prediction in cancers

Ensemble Classifier Based on Gene Synergistic Network Improves Breast Cancer Outcome Prediction

Hybrid gene selection approach using XGBoost and multi-objective genetic algorithm for cancer classification

Monte Carlo Simulation Based Gene Selection for Ovarian Cancer Chemotherapy Response Prediction with Microarray Data

Consensus Analysis of Multiple Classifiers Using Non-Repetitive Variables: Diagnostic Application to Microarray Gene Expression Data

Prediction of Treatment Recommendations Via Ensemble Machine Learning Algorithms for Non-Small Cell Lung Cancer Patients in Personalized Medicine

Improving accuracy for cancer classification with a new algorithm for genes selection

A Robust Predictor of Response to Preoperative Chemotherapy for Breast Cancer

Accurate Prediction And Elucidation Of Drug Resistance Based On The Robust And Reproducible Chemoresponse Communities

Breast Cancer Classification Using Gradient Boosting Algorithms Focusing on Reducing the False Negative and SHAP for Explainability

Machine learning predicts treatment sensitivity in multiple myeloma based on molecular and clinical information coupled with drug response